Immatics Ownership
| IMTX Stock | USD 7.18 0.09 1.24% |
Shares in Circulation | First Issued 2018-03-31 | Previous Quarter 106 M | Current Value 101.5 M | Avarage Shares Outstanding 70.3 M | Quarterly Volatility 13.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Immatics |
Immatics Stock Ownership Analysis
About 22.0% of the company shares are held by company insiders. The book value of Immatics was currently reported as 2.66. The company recorded a loss per share of 0.63. Immatics NV had not issued any dividends in recent years. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people. To learn more about Immatics NV call Harpreet Singh at 49 7071 5397 0 or check out https://www.immatics.com.Besides selling stocks to institutional investors, Immatics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Immatics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Immatics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Immatics Quarterly Liabilities And Stockholders Equity |
|
About 22.0% of Immatics NV are currently held by insiders. Unlike Immatics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Immatics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Immatics' insider trades
Immatics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Immatics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immatics NV backward and forwards among themselves. Immatics' institutional investor refers to the entity that pools money to purchase Immatics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ra Capital Management, Llc | 2024-09-30 | 1.8 M | Braidwell Lp | 2024-09-30 | 1.6 M | Wasatch Advisors Lp | 2024-09-30 | 872.5 K | Adage Capital Partners Gp Llc | 2024-09-30 | 721.3 K | Sphera Funds Management Ltd. | 2024-09-30 | 721.1 K | 683 Capital Management Llc | 2024-09-30 | 700 K | University Of Texas Investment Mgmt Co | 2024-09-30 | 697.4 K | Blackrock Inc | 2024-06-30 | 690.8 K | Artisan Partners Limited Partnership | 2024-09-30 | 661.3 K | Rtw Investments, Llc | 2024-09-30 | 10 M | Wellington Management Company Llp | 2024-09-30 | 9.7 M |
Immatics Outstanding Bonds
Immatics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immatics NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immatics bonds can be classified according to their maturity, which is the date when Immatics NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Immatics Corporate Filings
6K | 13th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F3 | 17th of October 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immatics Stock Analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.